Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 948723, 6 pages
http://dx.doi.org/10.1155/2015/948723
Research Article

The Protective Role of HLA-DRB113 in Autoimmune Diseases

1Immunogenetics Laboratory, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal
2Unit for Multidisciplinary Research in Biomedicine (UMIB), Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto (UP), Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal
3Department of Neurology, Centro Hospitalar do Porto-Hospital de Santo António (CHP-HSA), Largo Prof. Abel Salazar, 4099-001 Porto, Portugal
4Unidade de Imunologia Clínica (UIC), Centro Hospitalar do Porto-Hospital de Santo António (CHP-HSA), Largo Prof. Abel Salazar, 4099-001 Porto, Portugal
5Department of Dermatology, Centro Hospitalar do Porto-Hospital de Santo António (CHP-HSA), Largo Prof. Abel Salazar, 4099-001 Porto, Portugal
6Department of Internal Medicine, Centro Hospitalar do Porto-Hospital de Santo António (CHP-HSA), Largo Prof. Abel Salazar, 4099-001 Porto, Portugal
7Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA), Rua Alexandre Herculano No. 321, 4000-055 Porto, Portugal

Received 10 August 2015; Accepted 20 October 2015

Academic Editor: Carlo Perricone

Copyright © 2015 Andreia Bettencourt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shoenfeld, B. Gilburd, M. Abu-Shakra et al., “The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008,” Israel Medical Association Journal, vol. 10, no. 1, pp. 3–7, 2008. View at Google Scholar · View at Scopus
  2. J.-M. Anaya, L. Gómez, and J. Castiblanco, “Is there a common genetic basis for autoimmune diseases?” Clinical and Developmental Immunology, vol. 13, no. 2–4, pp. 185–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Cruz-Tapias, O. M. Pérez-Fernández, A. Rojas-Villarraga, A. Rodríguez-Rodríguez, M.-T. Arango, and J.-M. Anaya, “Shared HLA class II in six autoimmune diseases in Latin America: a meta-analysis,” Autoimmune Diseases, vol. 2012, Article ID 569728, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Anaya, “The autoimmune tautology,” Arthritis Research & Therapy, vol. 12, no. 6, article 147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. E. Smilek and E. W. St Clair, “Solving the puzzle of autoimmunity: critical questions,” F1000Prime Reports, vol. 7, article 17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Sprent and H. Kishimoto, “The thymus and central tolerance,” Transplantation, vol. 72, no. 8, supplement, pp. S25–S28, 2001. View at Google Scholar · View at Scopus
  7. J. A. Bluestone, “Mechanisms of tolerance,” Immunological Reviews, vol. 241, no. 1, pp. 5–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tsai and P. Santamaria, “MHC class II polymorphisms, autoreactive T-cells, and autoimmunity,” Frontiers in Immunology, vol. 4, article 321, Article ID Article 321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. T. K. Starr, S. C. Jameson, and K. A. Hogquist, “Positive and negative selection of T cells,” Annual Review of Immunology, vol. 21, pp. 139–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Palmer, “Negative selection—clearing out the bad apples from the T-cell repertoire,” Nature Reviews Immunology, vol. 3, no. 5, pp. 383–391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Lühder, J. Katz, C. Benoist, and D. Mathis, “Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities,” Journal of Experimental Medicine, vol. 187, no. 3, pp. 379–387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Schmidt, J. Verdaguer, N. Averill, and P. Santamaria, “A mechanism for the major histocompatibility complex-linked resistance to autoimmunity,” Journal of Experimental Medicine, vol. 186, no. 7, pp. 1059–1075, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Schmidt, A. Amrani, J. Verdaguer, S. Bou, and P. Santamaria, “Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules,” Journal of Immunology, vol. 162, no. 8, pp. 4627–4636, 1999. View at Google Scholar · View at Scopus
  14. S. Tsai, P. Serra, X. Clemente-Casares et al., “Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3471–3476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. K. W. Wucherpfennig and D. Sethi, “T cell receptor recognition of self and foreign antigens in the induction of autoimmunity,” Seminars in Immunology, vol. 23, no. 2, pp. 84–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Morris, K. E. Taylor, M. M. A. Fernando et al., “Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans,” The American Journal of Human Genetics, vol. 91, no. 5, pp. 778–793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Vasconcelos, C. Carvalho, B. Leal et al., “HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features,” Annals of the New York Academy of Sciences, vol. 1173, pp. 575–580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Furukawa, A. Kawasaki, S. Oka et al., “Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and 14:03,” PLoS ONE, vol. 9, no. 2, Article ID e87792, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Y. P. C. Ho, A. Barton, J. Worthington et al., “Investigating the role of the HLA-Cw06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 5, pp. 677–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Shawkatová, J. Javor, Z. Párnická et al., “HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population,” Folia Microbiologica, vol. 58, no. 4, pp. 319–324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Furukawa, S. Oka, K. Shimada, A. Hashimoto, and S. Tohma, “Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis,” Journal of Human Genetics, 2015. View at Publisher · View at Google Scholar
  22. S. T. Flam, R. Gunnarsson, T. Garen, B. A. Lie, and O. Molberg, “The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases,” Rheumatology, vol. 54, no. 3, pp. 528–535, 2015. View at Publisher · View at Google Scholar
  23. D. D. Gladman, T. N. Kung, F. Siannis, F. Pellett, V. T. Farewell, and P. Lee, “HLA markers for susceptibility and expression in scleroderma,” Journal of Rheumatology, vol. 32, no. 8, pp. 1481–1487, 2005. View at Google Scholar · View at Scopus
  24. B. A. C. Cree, “Multiple sclerosis genetics,” Handbook of Clinical Neurology, vol. 122, pp. 193–209, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Silva, C. Pereira, A. Bettencourt et al., “The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population,” Journal of the Neurological Sciences, vol. 258, no. 1-2, pp. 69–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Avidan, R. Le Panse, S. Berrih-Aknin, and A. Miller, “Genetic basis of myasthenia gravis—a comprehensive review,” Journal of Autoimmunity, vol. 52, pp. 146–153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Olerup and H. Zetterquist, “HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation,” Tissue Antigens, vol. 39, no. 5, pp. 225–235, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Candore, D. Lio, G. Colonna Romano, and C. Caruso, “Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions,” Autoimmunity Reviews, vol. 1, no. 1-2, pp. 29–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Collado, C. Guitart, M. Teresa Ciudad, I. Alvarez, and D. Jaraquemada, “The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: a clue for autoimmunity?” Frontiers in Immunology, vol. 4, article 442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Bruno and H. A. Lima, “HLA-A, -C, -B, and -DRB1 allelic and haplotypic diversity in bone marrow volunteer donors from northern Portugal,” Organs, Tissues & Cells, vol. 16, pp. 19–26, 2013. View at Google Scholar
  32. K. R. Jun, S.-E. Choi, C.-H. Cha et al., “Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations,” Journal of Korean Medical Science, vol. 22, no. 6, pp. 973–980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Oka, H. Furukawa, A. Kawasaki et al., “Protective effect of the HLA-DRB113:02 allele in Japanese rheumatoid arthritis patients,” PLoS ONE, vol. 9, no. 6, Article ID e99453, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Uçar, M. Karkucak, E. Alemdaroğlu et al., “HLA-DRB1 allele distribution and its relation to rheumatoid arthritis in eastern Black Sea Turkish population,” Rheumatology International, vol. 32, no. 4, pp. 1003–1007, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Tuokko, S. Nejentsev, R. Luukkainen, A. Toivanen, and J. Ilonen, “HLA haplotype analysis in Finnish patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 44, no. 2, pp. 315–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. D. van der Woude, B. A. Lie, E. Lundström et al., “Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB11301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations,” Arthritis & Rheumatism, vol. 62, no. 5, pp. 1236–1245, 2010. View at Publisher · View at Google Scholar
  37. A. H. M. van der Helm-van Mil, T. W. J. Huizinga, G. M. T. Schreuder, F. C. Breedveld, R. R. P. de Vries, and R. E. M. Toes, “An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility,” Arthritis and Rheumatism, vol. 52, no. 9, pp. 2637–2644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. M. Stassen, J. W. Cohen-Tervaert, S. P. M. Lems, B. G. Hepkema, C. G. M. Kallenberg, and C. A. Stegeman, “HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis,” Rheumatology, vol. 48, no. 6, pp. 622–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Michou, P. Croiseau, E. Petit-Teixeira et al., “Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 8, no. 3, article R79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. I. E. van der Horst-Bruinsma, H. Visser, J. M. W. Hazes et al., “HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis,” Human Immunology, vol. 60, no. 2, pp. 152–158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. D. L. Mattey, P. T. Dawes, M. A. Gonzalez-Gay et al., “HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis,” Journal of Rheumatology, vol. 28, no. 2, pp. 232–239, 2001. View at Google Scholar · View at Scopus
  42. J. van Heemst, D. T. Jansen, S. Polydorides et al., “Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis,” Nature Communications, vol. 6, article 6681, 2015. View at Publisher · View at Google Scholar
  43. H. M. Diepolder, M.-C. Jung, E. Keller et al., “A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B,” Clinical and Experimental Immunology, vol. 113, no. 2, pp. 244–251, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Ramezani, M. R. Hasanjani Roshan, E. Kalantar et al., “Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection,” Journal of Gastroenterology and Hepatology, vol. 23, no. 11, pp. 1716–1721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Fesel, M. Barreto, R. C. Ferreira et al., “Compensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferentiality modeling,” PLoS ONE, vol. 7, no. 3, Article ID e33992, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. L. Ferre, P. W. Hunt, D. H. McConnell et al., “HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses,” Journal of Virology, vol. 84, no. 21, pp. 11020–11029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. U. Malhotra, S. Holte, S. Dutta et al., “Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment,” The Journal of Clinical Investigation, vol. 107, no. 4, pp. 505–517, 2001. View at Publisher · View at Google Scholar · View at Scopus